Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors
US9102669B2 · kind B2 · utility
0Cited by
6References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2012 |
| Grant date | Aug 11, 2015 |
| Priority date | — |
| Expiry date | Dec 5, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to novel piperidinyl-pyridazinyl derivatives, pharmaceutical compositions containing them and their use as inhibitors of SCD1, useful in the treatment of obesity, type-II diabetes and other related metabolic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.